Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Efficacy and Optimal Dose of Sufentanil in Patient Controlled Analgesia After Moderate Surgery
NCT02503826Phase 4Unknown
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, double-blind trial of sufentanil in postoperative pain (3 arms), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Visual Analog Scale at 48 hours and Numerical Rating Scale at 48 hours. Status: unknown.
02
Drugs
sufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02503826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503826.